pillbase.ru

Padcev

Active substance: enfortumab vedotin

Enfortumab vedotin

Centralised EU authorisationActive

Marketing holder: Astellas Pharma Europe B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Падцев Онко
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 20 мг, 20 мг (original in Russian, GRLS)
    ЛП-№(002568)-(РГ-RU)
    Астеллас Фарма Юроп Б.В.
US 2
  • PADCEV EJFV
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · ENFORTUMAB VEDOTIN 20 mg/2mL
    51144-020
    SEAGEN INC.
  • PADCEV EJFV
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · ENFORTUMAB VEDOTIN 30 mg/3mL
    51144-030
    SEAGEN INC.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-4a9f-7664-a7a3-9dfa5bc662d8;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-6d64-7819-add8-fa4d5c3a2626,01a1208d-3496-79e6-bb75-487741389238;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005392
Registration status
Active
ATC code
L01FX13
Sources
  • product · EMA · EMEA/H/C/005392 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005392 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005392 · Verified 2026-10-09